Recruiting OBSERVATIONAL NCT07310537
Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling (ctDNA TAP)
Sponsor: Erasmus Medical Center
Conditions
Circulating Tumor DNA (ctDNA) Colorectal Cancer (Diagnosis) Colorectal Liver Metastasis (CRLM)
Interventions
Blood Collection - TAP® Device Blood Collection - Venous
Updated 2 times since 2026 Last updated: Jan 2, 2026 Started: Nov 17, 2025 Primary completion: Nov 30, 2026 Completion: Nov 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07310537, this observational or N/A phase trial focuses on Circulating Tumor DNA (ctDNA) and Colorectal Cancer (Diagnosis) and remains actively recruiting participants. Sponsored by Erasmus Medical Center, it has been updated 2 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Jan 2026 — Feb 2026 [monthly]
Recruiting
First recorded
Nov 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Erasmus Medical Center
Data source: Erasmus Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .